GB2446641B - Improved compositions and combinations 2 - Google Patents

Improved compositions and combinations 2

Info

Publication number
GB2446641B
GB2446641B GB0702883A GB0702883A GB2446641B GB 2446641 B GB2446641 B GB 2446641B GB 0702883 A GB0702883 A GB 0702883A GB 0702883 A GB0702883 A GB 0702883A GB 2446641 B GB2446641 B GB 2446641B
Authority
GB
United Kingdom
Prior art keywords
combinations
improved compositions
compositions
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0702883A
Other versions
GB0702883D0 (en
GB2446641A (en
Inventor
David John Grainger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TCP Innovations Ltd
Original Assignee
TCP Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TCP Innovations Ltd filed Critical TCP Innovations Ltd
Priority to GB0702883A priority Critical patent/GB2446641B/en
Publication of GB0702883D0 publication Critical patent/GB0702883D0/en
Publication of GB2446641A publication Critical patent/GB2446641A/en
Application granted granted Critical
Publication of GB2446641B publication Critical patent/GB2446641B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0702883A 2007-02-14 2007-02-14 Improved compositions and combinations 2 Expired - Fee Related GB2446641B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0702883A GB2446641B (en) 2007-02-14 2007-02-14 Improved compositions and combinations 2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0702883A GB2446641B (en) 2007-02-14 2007-02-14 Improved compositions and combinations 2

Publications (3)

Publication Number Publication Date
GB0702883D0 GB0702883D0 (en) 2007-03-28
GB2446641A GB2446641A (en) 2008-08-20
GB2446641B true GB2446641B (en) 2010-10-13

Family

ID=37908639

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0702883A Expired - Fee Related GB2446641B (en) 2007-02-14 2007-02-14 Improved compositions and combinations 2

Country Status (1)

Country Link
GB (1) GB2446641B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2475907A (en) 2009-12-04 2011-06-08 Tcp Innovations Ltd Composition comprising a mixture of clopidogrel and droloxifene

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202736A1 (en) * 2003-04-02 2004-10-14 Pharmaton S.A. Method of ameliorating side-effects of SERMs
CA2481664A1 (en) * 2004-09-30 2006-03-30 William Jia Prevention of breast cancer with novel selective estrogen receptor moldulators

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202736A1 (en) * 2003-04-02 2004-10-14 Pharmaton S.A. Method of ameliorating side-effects of SERMs
CA2481664A1 (en) * 2004-09-30 2006-03-30 William Jia Prevention of breast cancer with novel selective estrogen receptor moldulators

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Clarke et al; Circulation, Vol. 2001 No. 11. pages 1497-1502 *

Also Published As

Publication number Publication date
GB0702883D0 (en) 2007-03-28
GB2446641A (en) 2008-08-20

Similar Documents

Publication Publication Date Title
ZA201001300B (en) Antigen-asjuvant compositions and methods
EP2162004A4 (en) Antimicrobial compositions and uses thereof
IL202826A0 (en) New compounds and their uses 708
EP2219554A4 (en) Progesterone-containing compositions and devices
DK2139466T3 (en) Magnesium Compositions and Uses Thereof
GB0602325D0 (en) Virucidal compositions and uses
ZA201008887B (en) Oral compositions and uses thereof
GB2455539B (en) Anti-inflammatory compositions and combinations
ZA201007920B (en) Oral compositions and uses thereof
EP2046936A4 (en) Biocidal compositions and methods
EP2101731A4 (en) Endoxifen methods and compositions
GB0721291D0 (en) Methods and compositions
EP2088865A4 (en) Guggulphospholipid methods and compositions
GB0622399D0 (en) Novel compositions and uses thereof
GB0717376D0 (en) Composition and manufacture thereof
GB0617171D0 (en) Novel compositions and methods
EP1848438A4 (en) Diaminophenothiazine compositions and uses thereof
GB0702871D0 (en) Improved compositions and combinations 1
GB0719526D0 (en) Compositions and methods
IL201015A0 (en) New compounds and their uses 707
EP1998753A4 (en) High-deposition compositions and uses thereof
EP2247303A4 (en) Haemostasis- modulating compositions and uses therefor
IL202496A0 (en) Compounds and uses thereof 849
GB0715428D0 (en) Compositions and uses thereof
GB0701170D0 (en) Compositions and uses thereof

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20140214